Silodosin
Brand names: Urorec, Silodyx
Silodosin is a selective alpha-1A adrenoceptor antagonist used to treat the lower urinary tract symptoms of benign prostatic hyperplasia in men.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It selectively blocks alpha-1A adrenoceptors in the prostate, bladder neck and urethra, relaxing smooth muscle and reducing bladder outflow obstruction and associated voiding symptoms.
Prescribing in practice
- It commonly causes abnormal or retrograde ejaculation, and patients should be advised of this before starting treatment.
- It is associated with intraoperative floppy iris syndrome, so any planned cataract or glaucoma surgery should be flagged to the ophthalmologist before commencing.
- Caution is needed in renal or hepatic impairment and with concomitant potent CYP3A4 inhibitors or other antihypertensives because of the risk of hypotension.
Monitoring
Monitor symptom response and blood pressure, particularly for postural hypotension on initiation and dose changes.
Counselling the patient
- Reduced or absent semen on ejaculation is expected and not harmful.
- Tell your eye surgeon you take this medicine before any cataract operation.
- Stand up slowly, especially when first starting, to avoid dizziness.
Evidence & guidelines
Alpha-blockers are recommended by NICE for moderate to severe lower urinary tract symptoms in benign prostatic hyperplasia; see the SPC for product-specific cautions.
Reference: NICE NG97; EAU Guidelines on BPH; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.